Trademarkia Logo

Australia

AU$
PROGENTOS THERAPEUTICS
Protected: Registered/protected

Last updated on 8 Jan 2025

Owner Info

Progentos Therapeutics, Inc.

200 Dexter Ave

Watertown MA 02472, UNITED STATES OF AMERICA

Serial Number

2491023 filed on 12 Aug 2024

Correspondent

Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.

1101 K Street, N.W., 10th Floor,

Washington DC 20005,

UNITED STATES OF AMERICA

PROGENTOS THERAPEUTICS

Classification Information


Class [005]
Pharmaceutical preparations used to treat diseases of the central nervous system, neurological diseases, autoimmune disorders, diseases of the central Read More

Class [042]
Medical and scientific research and development in the field of diseases of the central nervous system, neurological diseases, autoimmune disorders, d Read More

Mark Details


Serial Number

2491023

Registered On

12 Aug 2024

Renewal On

12 Aug 2034

Mark Type

WORD

Priority Claim (Convention Details)


Date

14 Feb 2024

Mark Type

US

Legal History


Show more

Status DateAction Taken
8th Jan 2025International Registration in Australia Protected correspondence sent
7th Jan 2025IP Right Registration Published
7th Jan 2025Status change to Registered/Protected
22nd Oct 2024Application Accepted correspondence sent
21st Oct 2024IP Right has been Examined
21st Oct 2024IP Right Acceptance Published
21st Oct 2024Status change to Accepted
21st Oct 2024Awaiting examination
21st Oct 2024Examination expedited
17th Oct 2024IP Right Filed Published